IndraLab

Statements


P5091 activates Neoplasms. 6 / 6
| 6

reach
"The USP7 inhibitor P5091 has been demonstrated to effectively inhibit Wnt signaling and tumor growth, underscoring the pivotal role of USP7 in this context [28]."

reach
"For example, P5091 was able to induce apoptosis in non-neuroendocrine lung (L-NEC) tumor while P22077 reactivated p53 and induced apoptosis in human neuroblastoma (NB) and overcame cellular chemoresis[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"When evaluated in mice with Lewis lung carcinoma, USP7 inhibitor P5091 slowed tumor growth and promoted the infiltration of M1 macrophages and IFN-γ-expressing CD8+ T cells."

reach
"For p53-deficient NSCLC, combination treatment with melatonin and the USP7 inhibitor P5091 could significantly inhibit tumor growth."

reach
"Administration of USP7 inhibitor P5091 (25 mg/kg) has been found to decrease the growth rate of tumor in vivo."

reach
"Furthermore, P5091 treatment caused FOXP3 loss in Treg cells decreased the proportion of Treg cells in tumor bearing mice."